Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
Global Epilepsy Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025
... to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Epilepsy Drugs market ... Read More
-
Epilepsy - Market Insight, Epidemiology and Market Forecast -2030
... EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Epilepsy market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Epilepsy market size from ... Read More
-
Epilepsy - Epidemiology Forecast to 2030
... Japan. Epilepsy Understanding According to the American Association of Neurological Surgeons, epilepsy is a disorder of the brain characterized by repeated seizures. A seizure is usually defined as a sudden alteration of behavior due to ... Read More
-
Lennox Gastaut Syndrome - Epidemiology Forecast to 2030
... and Japan. Lennox–Gastaut Syndrome (LGS) Disease Understanding Lennox–Gastaut syndrome (LGS) is a severe pediatric epilepsy syndrome characterized by multiple pharmaco-resistant seizure types, including tonic, atypical absences, and tonic or atonic drop attacks, and the presence ... Read More
-
Global Antiepileptic Drugs Market Research Report 2020-2024
... and COVID-19 epidemic, it will have a big influence on this market. Antiepileptic Drugs Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s ... Read More
-
Epilepsy - Pipeline Review, H2 2020
... Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods ... Read More
-
Epilepsy Therapeutic Market in APAC 2020-2024
... 3% during the forecast period. Our reports on epilepsy therapeutic market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. ... Read More
-
Deep Brain Stimulation Devices
... year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 10.1% over the analysis period 2020-2027. Parkinson’s, one of the segments analyzed in the report, is ... Read More
-
Lennox Gastaut Syndrome – Market Insights, Epidemiology, and Market Forecast—2030
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Lennox Gastaut Syndrome (LGS) market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, ... Read More
-
Neurosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
... instruments that are used for conducting surgeries and treating various pathologies in the central and peripheral nervous systems. They are primarily used for diagnosing, preventing and treating conditions such as Parkinson’s, Alzheimer’s, depression, epilepsy and ... Read More
-
Epilepsy Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)
... years and increasing cases of epilepsy across the globe. Epilepsy is a central nervous system (CNS) disorder in which brain activity becomes abnormal, resulting in seizures or periods of unusual behavior, and sensations. It can ... Read More
-
Tonic-Clonic (Grand Mal) Seizure Global Clinical Trials Review, H1, 2020
... trials scenario. This report provides top line data relating to the clinical trials on Tonic-Clonic (Grand Mal) Seizure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
A Global Neurostimulation Devices Market By Product Type (SCS, DBS, SNS, VNS, and GES), By Applications Type (Pain Management, Urinary & Fecal Incontinence, and Epilepsy), By End-users (Hospitals and Trauma Centers), and By Regions (North America, Europe
... America, Europe, APAC, and RoW) – Forecast up to 2025 Global Neurostimulation Devices Market By Product Type (SCS, DBS, SNS, VNS,and GES), By Applications Type (Pain Management, Urinary & Fecal Incontinence,and Epilepsy), By End-users (Hospitals ... Read More
-
Global Epilepsy Drugs Market - 2019-2026
... as a nerve disorder where the nerves in the brain loose the regular function or disturbed which can lead to seizure. During a seizure, a person experiences abnormal behavior, symptoms and sensations, sometimes including loss ... Read More
-
Global Deep Brain Stimulation Devices Market by Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, and Others) and End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others): Opp
... Forecast, 2019–2026 The global deep brain stimulation monitoring market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.Deep brain stimulation is an electrical ... Read More
-
Epilepsy– Competitive Landscape, Market and Pipeline Analysis, 2020
... are much more benign. In epilepsy, the normal pattern of neuronal activity becomes disturbed, causing strange sensations, emotions, and behavior or sometimes convulsions, muscle spasms, and loss of consciousness. Epilepsy may develop because of an ... Read More
-
Neuromodulation Market by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) - Global Forecast to
... to grow at a CAGR of 8.6% during the forecast period (2020–2025).” The global neuromodulation market size is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR ... Read More
-
Developmental and Epileptic Encephalopathies (DEE)—Epidemiology Forecast to 2028
... Spain, Italy, France, and United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2017–2028 Developmental and Epileptic Encephalopathies (DEE) Epidemiology ... Read More
-
Partial Epilepsy - Pipeline Insight, 2020
... Epilepsy Pipeline Landscape Is Provided, Which Includes The Disease Overview And Partial Epilepsy Treatment Guidelines. The Assessment Part Of The Report Embraces In-Depth Partial Epilepsy Commercial Assessment And Clinical Assessment Of The Partial Epilepsy Pipeline ... Read More
-
KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) - Pipeline Insight, 2020
... Developmental and Epileptic Encephalopathy (KCNQ2-DEE) Market. A Detailed Picture Of The KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) Pipeline Landscape Is Provided, Which Includes The Disease Overview And KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) Treatment Guidelines. ... Read More
-
Epilepsy - Pipeline Insight, 2020
... Provided, Which Includes The Disease Overview And Epilepsy Treatment Guidelines. The Assessment Part Of The Report Embraces In-Depth Epilepsy Commercial Assessment And Clinical Assessment Of The Epilepsy Pipeline Products From The Pre-Clinical Developmental Phase To ... Read More
-
Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030
... Epidiolex (cannabidiol) in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2017–2030 is provided in this report along with a detailed description ... Read More
-
Developmental and Epileptic Encephalopathies (DEE)- Market Insights, Epidemiology and Market Forecast-2028
... Epileptic Encephalopathies (DEE) in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted ... Read More
-
Drug Resistant Epilepsy - Pipeline Insight, 2020
... Of The Drug Resistant Epilepsy Pipeline Landscape Is Provided, Which Includes The Disease Overview And Drug Resistant Epilepsy Treatment Guidelines. The Assessment Part Of The Report Embraces In-Depth Drug Resistant Epilepsy Commercial Assessment And Clinical ... Read More
-
Refractory Epilepsy- Pipeline Insight, 2020
... Epilepsy Pipeline Landscape Is Provided, Which Includes The Disease Overview And Refractory Epilepsy Treatment Guidelines. The Assessment Part Of The Report Embraces In-Depth Refractory Epilepsy Commercial Assessment And Clinical Assessment Of The Refractory Epilepsy Pipeline ... Read More
